The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of immunotherapy of high-risk neuroblastoma patients with long term infusion of dinutuximab beta with survival over short term infusion: Results from the HR-NBL1/SIOPEN trial.
 
Ruth Ladenstein
Consulting or Advisory Role - Apeiron Biologics; Boehringer Ingelheim; EUSA Pharma (Inst)
Research Funding - Apeiron Biologics (Inst); EUSA Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Apeiron Biologics (Inst); EUSA Pharma (Inst)
Expert Testimony - Apeiron Biologics; EUSA Pharma
 
Ulrike Poetschger
No Relationships to Disclose
 
Dominique Valteau Couanet
Honoraria - Bellerophon Theraeutics
Consulting or Advisory Role - Orphelia Pharma
Research Funding - Orphelia Pharma (Inst)
 
Juliet Gray
Consulting or Advisory Role - EUSA Pharma; Norgine; Roche; SERVIER; YmAbs Therapeutics Inc
Research Funding - Bristol-Myers Squibb; Celgene
 
Roberto Luksch
No Relationships to Disclose
 
Aleksandra Wieczorek
Honoraria - Recordati
Consulting or Advisory Role - Recordati
Research Funding - Recordati
Expert Testimony - Recordati
Travel, Accommodations, Expenses - Recordati
 
Adela Canete
No Relationships to Disclose
 
Shifra Ash
No Relationships to Disclose
 
Maja Beck Popovic
No Relationships to Disclose
 
Godfrey Chan
No Relationships to Disclose
 
Ellen Ruud
No Relationships to Disclose
 
Kim Vettenranta
No Relationships to Disclose
 
Henrik Schroeder
No Relationships to Disclose
 
Cormac Owens
No Relationships to Disclose
 
Hans Loibner
Stock and Other Ownership Interests - Anyxis Immuno-Oncology; Apeiron Biologics
Patents, Royalties, Other Intellectual Property - Apeiron Biologics
 
Sabine Taschner-Mandl
No Relationships to Disclose
 
Sabine Sarnacki
No Relationships to Disclose
 
Holger Lode
Stock and Other Ownership Interests - Anyxis Immuno-Oncology
Honoraria - Recordati
Consulting or Advisory Role - Recordati
Research Funding - EUSA Pharma
Travel, Accommodations, Expenses - Recordati